Authored by Katrina Adlerz, Ph.D., Scientist, Analytics, Product & Process Development & Josephine Lembong, Ph.D., Scientist, Analytics, Product & Process Development The 2019 International Society for Cell and Gene Therapy (ISCT) ... More
Authored by Joseph Candiello, Ph.D., Technical Application Specialist Figure 1. Current and emerging applications using hMSCs as a critical raw material. Human mesenchymal stem/stromal cells (hMSCs) are a critical starting ... More
Authored by Katrina Adlerz, Ph.D. Scientist, Analytical Development, RoosterBio Inc. RoosterBio attended the International Society for Cell Therapy annual meeting, held May 2-5, 2018 in Montreal, which brought together leaders ... More
RoosterBio was founded to accelerate the development of the Regenerative Medicine field by utilizing advancements in Manufacturing Sciences. As such, we have long been involved in laying the groundwork for a Technology ... More
Human mesenchymal stem or stromal cells (hMSCs) are an integral part of cell-based therapeutics, with over 400 clinical trials recently completed or in progress using hMSCs. As more research teams ... More
We are always looking for ways to enable the commercialization of Cell-based Therapy and Technology. The ultimate success of the field is dependent on the convergence of several technology fields, ... More
Last week was the 4th Annual IBC Cell Therapy Bioprocessing Conference. IBC (home of the BioProcess International conference) was the first conference organizer to dedicate a focused meeting on Cell Therapy Manufacturing Technologies 4 ... More
From www.CellTherapyWonk.com Fall is almost here, and that means it is Cell Therapy Bioprocessing and Manufacturing conference season. This year it started a few weeks earlier as conference organizer CHI ... More
Closed system 10 layer and media bags are now readily available from several vendors. Fall is almost here, and that means it is Cell Therapy Bioprocessing and Manufacturing conference season. ... More